How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Close this folder4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
View the documentAdapting the therapeutic classification system of the WHO model formulary
View the documentOptions for adapting information from the WHO model formulary in the national formulary
Close this folderAddition of locally important, specific information to the WHO model formulary text
View the documentIntroductory text of therapeutic sections
View the documentMonographs
View the documentBrand name(s)
View the documentPrice
View the documentWriting new material for the national formulary
View the documentLanguage, style and presentation
View the documentTechnical copy-editing
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Introductory text of therapeutic sections

General statements about national clinical guidelines, policies and warnings can be added to the introductory text using the uniform text style mentioned above. For example, a summary of the national tuberculosis treatment schedules can be given a prominent place, with a clear title at the beginning of Section 6.2.4 “Antituberculosis drugs”, whereas contact details for treatment centres for multi-drug resistant tuberculosis in the country can be inserted near to the relevant WMF text.

The Producing drug and therapeutic information - the Malawi approach to developing standard treatment guidelines4 manual gives useful information and practical tips for those who may be simultaneously developing or revising national standard treatment guidelines while working on the NF.

4 Available on the Internet at: http://www.who.int/medicines/library/dap/who-dap-94-14/who-dap-94-14.doc

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014